10 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
immunotherapy pre-treatment (prior to TIL extraction): optimize TIL harvest and broaden access to indications that are currently less amenable to generating … ) treatment of the patient with viral immunotherapy prior to TIL extraction to optimize TIL harvest and broaden applicability to additional tumor types
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
5 Mar 24
Regulation FD Disclosure
8:30am
harvest Pre-treatment: Expand access to indications less amenable to TIL therapy by optimizing TIL extraction Reprogram the immunosuppressive tumor
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
prior to TIL extraction to optimize TIL harvest and broaden applicability to additional tumor types with low immune cell infiltration and (2) treatment
424B4
j4stqzunm7z4t06l
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
6ni7 x6bptyxes
23 Jun 23
IPO registration (amended)
9:49pm
S-1
4feshw2ovs6q
12 Jun 23
IPO registration
4:28pm
DRS
uj9uobg3gwc
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next